Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African American women 23 35 years old

Wednesday, April 6, 2016

Authors:
Erica E. Marsh, M.D., M.S.C.I., Lia A.…

Read More

Comparative assessment of five serum antimullerian hormone assays for the diagnosis of polycystic ovarian syndrome

Friday, April 1, 2016
The performance of the different commercial antimullerian hormone assays for polycystic ovary syndrome diagnosis is comparable, but different threshold values should be used for automatic and manual assays.

Read More

Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone A multivariate analysis of over 5000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012 2013

Monday, February 1, 2016
Prognostic indicators of assisted reproductive technology cycles with ultralow antimullerian hormone are identified and assessed by multivariate analysis of over 5,000 autologous cycles from the 2012–2013 Society for Assisted Reproductive Technology Clinic Outcome Reporting System database.

Read More

Antimüllerian hormone Correlation with age and androgenic and metabolic factors in women from birth to postmenopause

Monday, February 1, 2016
Antimullerian hormone, which elevates from birth to 18 years of age and declines thereafter, is positively correlated with androgen levels in adolescent and reproductive-aged women.

Read More

Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation day

Monday, November 30, 2015
Antimullerian hormone (AMH) concentrations vary across ovulatory menstrual cycles with a periovulatory base and lower luteal phase levels. The number of antral follicles may be estimated from the level of AMH.

Read More

Pregnancy associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels

Thursday, October 29, 2015
Pregnancy-associated plasma protein A in human follicular fluid from follicles with different diameters shows highly significant associations with sex-steroids and antimullerian hormone, suggesting important functions of insulin-like growth factors.

Read More

Antimullerian hormone: prediction of cumulative live birth in gonadotropin releasing hormone antagonist treatment for in vitro fertilization

Tuesday, September 29, 2015
Although antimullerian hormone added some value to predicting cumulative live birth rate, its predictive accuracy was only modest.

Read More

Antimullerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng mL versus 1 4 ng mL

Tuesday, September 1, 2015
Antimullerian hormone (AMH) levels <1 ng/mL are associated with a statistically significantly lower likelihood of supernumerary good-quality blastocyst cryopreservation as compared with AMH levels between 1 and 4 ng/mL.

Read More

Personalized prediction of live birth Are we there yet

Thursday, July 30, 2015

Authors:
David B. Seifer, M.D., Reshef Tal, M.D., Ph.D.…

Read More

Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve A case control study

Wednesday, April 29, 2015
Laparoscopic stripping of recurrent ovarian endometriomas decreases antimullerian hormone levels, increases basal FSH, and decreases the antral follicle count and volume of the operated ovary.

Read More

Toward a better follow up of ovarian recovery in young women after chemotherapy with a hypersensitive antimullerian hormone assay

Wednesday, July 30, 2014
The hypersensitive PicoAMH assay, by its capacity to detect low levels of blood AMH, allows a more accurate prediction of menstrual cycle recovery in young women after chemotherapy.

Read More

Role of vitamin D in ovarian physiology and its implication in reproduction A systematic review

Wednesday, July 30, 2014
Vitamin D plays an important role in steroidogenesis, follicular development, ovarian reserve measures/markers, and IVF outcome. Vitamin D might have a beneficial reproductive effect in vitamin D–deficient women with polycystic ovary syndrome.

Read More

Age specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome

Wednesday, June 25, 2014
Age-specific antimullerian hormone (AMH) references were determined in women with and without polycystic ovary syndrome (PCOS). AMH levels were higher in women with PCOS than in those without PCOS. AMH correlated well with age and antral follicle count.

Read More

Ethnicity as a determinant of ovarian reserve Differences in ovarian aging between Spanish and Indian women

Wednesday, June 25, 2014
Ovaries from Indian women seem to age at an earlier stage than those of Spanish women. We observed a 6-year difference between Indian and Spanish women.

Read More

Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations to anti Müllerian hormone free testosterone and glucose disposal rate

Sunday, June 1, 2014
Magnetic resonance imaging yielded higher antral follicle counts (AFC) than previously reported. AFC, antimullerian hormone, and free testosterone discriminated with high accuracy between women with polycystic ovary syndrome and controls.

Read More

Comparability of antimullerian hormone levels among commercially available immunoassays

Sunday, June 1, 2014
Measurement of antimullerian hormone (AMH) levels with a highly sensitive ELISA kit maximized detection at very low levels; conversion of AMH levels between different immunoassays is potentially highly inaccurate.

Read More

Increased expression of antimullerian hormone and its receptor in endometriosis

Wednesday, April 30, 2014
Endometrium and endometriotic lesions express high levels of antim€ullerian hormone and its receptor, without any contribution to circulatory levels.

Read More

Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome

Monday, March 31, 2014
Antimüllerian hormone is highly correlated with number of eggs retrieved. Very low levels are associated with diminished yet reasonable pregnancy rates, mediated through number of oocytes retrieved as opposed to oocyte quality.

Read More

Preventing ovarian hyperstimulation with gonadotropin releasing hormone agonist trigger Is anything perfect

Monday, March 31, 2014
Reflections on "Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol" by Fatemi et al.

Read More

Female age related fertility decline

Thursday, February 20, 2014
Education and enhanced awareness of the effect of age on fertility is essential in counseling the patient who desires pregnancy.

Read More

Decline of serum antimüllerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts A prospective cohort study

Friday, January 31, 2014
Bilaterality is the only significant factor in predicting the rate of decline of antim€ullerian hormone levels after laparoscopic ovarian cystectomy.

Read More

Impact of antimullerian hormone assays on the outcomes of in vitro fertilization a prospective controlled study

Tuesday, December 31, 2013
The AMH assays reduced the cancellation rate after ovarian stimulation and helped some patients not to begin IVF stimulation because of their low AMH level.

Read More

FSHB 211 and FSHR 2039 are associated with serum levels of follicle stimulating hormone and antimüllerian hormone in healthy girls a longitudinal cohort study

Monday, September 30, 2013
FSHB GG+FSHR AA is the most favorable genotype for male gonadal function, but it has never been evaluated in girls. Healthy girls with this genotype have increased follicle-stimulating hormone and reduced antimüllerian hormone.

Read More

Serum antimüllerian hormone in response to dietary management and or physical exercise in overweight obese women with polycystic ovary syndrome secondary analysis of a randomized controlled trial

Monday, September 30, 2013
Randomized intervention with diet, but not exercise or combined intervention, reduces serum AMH levels in association with decreased T in obese women with PCOS, whereas weight loss has no significant influence.

Read More

Antimüllerian hormone inhibits follicle stimulating hormone induced adenylyl cyclase activation aromatase expression and estradiol production in human granulosa lutein cells

Wednesday, July 31, 2013

Capsule:
Antimullerian hormone acts through type II AMH receptor to inhibit FSH-induced adenylyl cyclase activation in hGL cells and subsequently suppresses aromatase expression and E2 production.…

Read More

Does the time interval between AMH serum sampling and initiation of ovarian stimulation affect its predictive ability in IVF ICSI cycles with a GnRH antagonist A retrospective single center study

Wednesday, July 31, 2013

Capsule:
A 12-month time interval between initial antimullerian hormone (AMH) measurement and commencement of ovarian stimulation does not adversely affect the ability of AMH to identify poor and excessive ovarian response.…

Read More

Why we may abandon basal follicle stimulating hormone testing A sea change in determining ovarian reserve using antimüllerian hormone

Friday, May 31, 2013
Antimullerian hormone is a more informative and therefore a better serum test of ovarian reserve than basal FSH.

Read More

Use of antimüllerian hormone the risks of interpreting ovarian reserve markers in isolation

Friday, May 31, 2013
Reflections on "Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimullerian hormone" by Toner et al.

Read More

Peripubertal changes in circulating antimullerian hormone levels in girls

Friday, May 31, 2013
Rate of ovarian primordial follicle recruitment increases prepubertally then declines again following the onset of puberty, while ovarian follicle activity continues to increase. These changes seem to track with the age of menarche.

Read More

Antimüllerian hormone is the writing on the wall for antral follicle count

Tuesday, April 30, 2013
Reflections on "Antimüllerian hormone in GnRH antagonist cycles: Prediction of ovarian response and cumulative treatment outcome in good-prognosis patients" by Arce et al.

Read More

Translate »